Back to all studies
🧴
Phase 4
Dermatology
in-person
A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic Dermatitis (Eczema) and Hig…
Sponsored by Eli Lilly and Company
Compensation
Compensation not listed. Many clinical trials cover travel or time, but payment isn't guaranteed. Ask the study team.
Duration
3 months
Location
Nationwide
About this study
The purpose of this study is to measure how well taking lebrikizumab alone works for participants with fewer places on the body with eczema (atopic dermatitis), but these places may be very itchy. Participation in this study will last up to approximately 38 weeks (9 and a half months) including 24 weeks (6 months) of treatment.
Who can participate
- • Adults aged 12–99
- • All genders welcome
- • Diagnosed with or experiencing atopic dermatitis
- • Able to attend in-person clinic visits
What's included
- • Compensation not listed. Many clinical trials cover travel or time, but payment isn't guaranteed. Ask the study team.
- • All study-related medical care at no cost
- • Lab work, screenings, and physician consultations
- • Study medication or treatment provided
IRB-approved study. Free to apply. Your information is kept confidential.
Ready to Find a Research Study?
Explore clinical trials and paid research opportunities. Compensation varies by study and is never guaranteed.